Adalimumab vs Ranitidine

## Adalimumab vs Ranitidine: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Ranitidine**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Ranitidine**: Competitive H2 receptor antagonist.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Ranitidine — 2-3 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Ranitidine — C13H22N4O3S.

**Molecular Weight**: Adalimumab — N/A; Ranitidine — 314.4050 g/mol.

**Type**: Adalimumab — Antibody; Ranitidine — Small molecule.